BioBlast Pharma Names Theresa (Terri) Stevens as Chief Corporate Development Officer

By: via Benzinga
BioBlast Pharma Ltd., (Nasdaq: ORPN) announced today that it has appointed Theresa (Terri) Stevens to the newly-created position of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.